CME & CPD Accredited 7th International Conference on Brain Disorders and Therapeutics
Rome, Italy
Dario Furnari is Ph.d. in Applied Biomedical Sciences in the neuroscience and traumatology and neuropharmacology sector
The lines of research on which he worked at the University of Catania, Department of Biotechnology and Biomedical Sciences, section of applied physiology and kinesiology and motion control, have been in the field of neuroscience, in particular in the role of beta-amyloid and glycoprotein F3 in the synaptic plasticity of hippocampal memory of mice and then in Alzheimer's disease; he dealt with behavior and various behavioral tests in mice; of electrophysiology of in vitro slices of hippocampus, stereotaxy and cannulation implantation, administration of drugs and animal welfare.
D. Ian James Martins is an Editor/Reveiwer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an H-index of 64, (ResearchGate STATs (27), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The citations past 27 years have accumulated to >4584. Ian James Martins - Semantic Scholar https://www.semanticscholar.org/author/Ian-James-Martins/5258067. Semantic Scholar profile for Ian James Martins, with fewer than 50 highly influential citations RESEARCHGATE ANALYSIS: Ian J Martins | Ph D | Centre of Excellence for Alzheimer's Disease ...https://www.researchgate.net/profile/Ian_Martins2 under Ian James Martins’ name places publication RG score (> 96%) of international SCIENTISTS. ORCID CONNECTING RESEARCHER: Editorial Team www.macrothink.org/journal/index.php/jfs/about/editorialTeamBio/13511 Editorial Team. Ian James Martins. Ian James Martins Mail · http://orcid.org/0000-0002-2390-1501. Edith Cowan University, Australia. Prestigious Recognition of Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). Certificates from various international conferences have been received in relation to anti-aging, health and disease. Keynote addresses at, Biomedicine 2018 (Osaka, Japan), Global Experts Meeting on Diabetes, Hypertension, Metabolic Syndrome 2018 (Melbourne, Australia), Immunology World 2018 (Amsterdam, Netherlands), Laboratory Medicine 2018 (Berlin, Germany), Innovate Pharma 2017 (Sydney, Australia), Innovate Neurology 2017(Sydney, Australia) World Diabetes and Endocrinology Summit-2017 (Dubai), Pharmacology and Ethnopharmacology 2016 (Chicago, USA) and AGHC 2016 (1st Plenary Speaker, Kaohsiung, Taiwan). Chair/Co-chair Sessions on Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine etc, 13th Interantional Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Pipeline 1: Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Programme Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethanopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Research Activity Statistics have been provided by Publons with comparison to other researchers. Ian James Martins is now in the 98th percentile as assessed for Publons users by merit. Dr Ian Martins is a reviewer for approx. 47 journals over the past 5 years.
Chronic Disease, Anti-Aging and Global Health
DR. ALAIN L. FYMAT, PhD, PhD is a medical-physical scientist and an educator. He is the current President/CEO and Professor at the International Institute of Medicine & Science with a previous appointment as EVP/COO and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science. He is also Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a frequent Keynote Speaker and International Organizing Committee member at several international scientific conferences. He has lectured extensively in the U.S., Europe, Asia and Africa. He has published ~ 425 scholarly scientific publications and books. He is also Editor-in-Chief, Honorable Editor or Editor of 54 scientific Journals. Dr. Fymat is a Board member of several institutions, a member of the New York Academy of Sciences and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO. His current research interests are focused on neurodegenerative diseases (Alzheimer, Parkinson, epilepsy, dementias and others), oncology, molecular/precision/personalized medicine, and nanomedicine and nanobiotechnology.
He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), and Physics at several U.S. and European Universities (University of California at Los Angeles, University of Southern California, Loma Linda University, California; University of Lille, France). Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center.
-1565153325857.jpg)
Prof. Emeritus Radu Mutihac is Chair of Medical Physics Section, University of Bucharest, and works in Neuroscience, Signal Processing, Microelectronics, and Artificial Intelligence. As postdoc/research associate/visiting professor/full professor, he run his research at the University of Bucharest, International Centre for Theoretical Physics (Italy), Ecole Polytechnique and Institut Henri Poincaré (France), KU Leuven (Belgium). Data mining and exploratory analysis of neuroimaging time series were addressed during two Fulbright Grants in Neuroscience (Yale University, CT, and University of New Mexico, NM, USA). His research in fused biomedical imaging modalities was carried out at the Johns Hopkins University, National Institutes of Health, and Walter Reed Army Institute of Research, MD, USA.
In 2008, Prof. Mutihac was nominated PhD student supervisor in the field of Physics at the University of Bucharest, Romania. Prof. Mutihac is member of the ISMRM, ESMRMB, OHBM, Romanian US Alumni Association, and fellow of Signal Processing and Neural Networks Society IEEE, as well as referee for several journals of the Institute of Physics (London, UK), Neural Networks (Elsevier), IEEE Transactions on Image Processing, and evaluator/expert for the ISMRM, OHBM, ARACIS, CNCSIS, UEFISCDI, The Romanian – U.S. Fulbright Commission, and the European Commission (FP7, H2020). Prof. Mutihac published over 120 scientific papers in reputed peer-reviewed journals, 12 monographs, and contributed with chapters in other 10 textbooks published by renowned scientific publishing houses. He participated in more than 150 scientific meetings with posters and oral presentations, seminars, invited and plenary lectures, as well as acting as member of the organizing committees, special session organizer, chairperson, and keynote speaker. Following his scientific activity, Prof. Mutihac has been nominated scientific referee for 12 journals, such as IOP, IEEE journals and alike, as well as Member of the Editorial Board of several journals in the field of Neuroscience: J. Romanian College of Medical Physicists, J. Childhood and Developmental Disorders, J. Neurology and Clinical Neuroscience, Medical and Clinical Reviews, J. of Translational Neurosciences, Epilepsy J., The Neurologist - Clinical and Therapeutics J., Advances in Neurology and Neuroscience., and J. of Neuroscience and Neurological Surgery.
Prof. Ching-Kuan Liu, MD, PhD was born in Kaohsiung, Taiwan in 1956. He graduated from the Kaohsiung Medical University (KMU) School of Medicine with honors such as being the commencement speaker on commencement ceremony and receiving the “Medal of Four Characters” in 1982. He completed his residency training in Neurology at KMU hospital. Subsequently, he received his master and PhD degrees from Graduate Institute of Medicine at KMU, where he was a distinguished graduate. He completed the Neurobehavior Fellowship Program and was a Clinical Instructor at Reed Neurological Institute of UCLA from 1988 to 1990. After returning to Taiwan, he became the Director of the Graduate Institute of Behavioral Sciences of KMU, the Chairman of the Department of Neurology of KMU & Hospital , the Dean of InfoTech of KMU, the Vice-Superintendent of the KMU Hospital, and the Superintendent of Kaohsiung Municipal Hsia-Kang Hospital. He just finished two 3-year terms as President of Kaohsiung Medical University. He earned the “Paragon of Taiwanese Medical Doctors Award” from the Taiwan Medical Association in 2015.
The research we do is both clinical and fundamental. We focus on many aspects, including the well-being of people. Thus we work on the problem of sleep from two different angles. On the one hand, apneas that are partly due to an anomaly of the oro-facial sphere and a neurological problem. We are funding a job to create a new measuring device that can be used on an outpatient basis to prevent hospitalization. On the other hand, the fragmentation of sleep, which is found in all the intellectual and pathological deficiencies of neuronal aging (Alzheimer, Parkinson for example). Eye problems are also an important research topic because trisomy 21 very often causes vision problems, which are very little taken care of. As we age, early cataracts or other ocular diseases such as glaucoma, keratocones develop. Another meaning, impacted: hearing. People with trisomy 21 have often made otitis recurring when they were children, sometimes giving them a partial deafness which requires that they can be paired and receive medical attention. Studies are also done in dermatology because they have very dry skin. Dentition is a field of research still little explored that will have to be taken into consideration. There is also a tendency to obesity. Nutrition programs exist but these must be accompanied by a sport. Life expectancy has increased significantly (about 65-70 years) because contrary to popular belief, We are also interested in the place of people with trisomy 21 in our society. It goes through school integration by allowing them to go to school. The big victory is the establishment of help with school life for children with trisomy 21 initiated by a small association "Growing up at school" and taken over by Trsiomie 21 France, which now also benefits children with an autistic syndrome . Another societal issue is the management of sexuality and contraception. This subject is still taboo and we are very late in France on this issue.
-1582349756466.jpg)
Dr. Rajendra D. Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.
Dr. Rajendra D. Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.